首页> 外文期刊>Cureus. >New Trends in the Utilization of Intravenous Fluids
【24h】

New Trends in the Utilization of Intravenous Fluids

机译:静脉内液体利用的新趋势

获取原文
       

摘要

Intravenous fluids (IVFs) are the most commonly used drugs in hospitalized patients. Knowledge of the indications and pharmacokinetics of IVFs is critical for all medical disciplines. Isotonic saline (normal saline, 0.9% NS) is the most utilized intravenous solution. Isotonic saline effectively expands the intravascular compartment, as one-quarter of the infusate goes intravascularly, while the remaining three-quarters go into the interstitial space. The proper use of IVFs in different clinical scenarios is paramount. IVFs differ with regard to their half-life, intravascular volume expansion, preparation, and cost. Crystalloids are more commonly utilized due to their relatively low cost and availability. Colloids are very advantageous in cases of shock or hemorrhage, as they remain in the intravascular space, thus facilitating an increase in blood pressure (BP) prior to blood administration. Colloids are also advantageous in cases of burns and severe hypoglobulinemia. Human albumin (5%, 20%, and 25%) is the most used colloid solution. It remains intravascularly provided and there is no capillary leak as in systematic inflammation.?The goal in hospitalized patients is timely and adequate intravenous fluid resuscitation. Utilization of a large volume of isotonic saline may lead to hypervolemia, hypernatremia, hyperchloremia, metabolic acidosis, and hypokalemia. The use of balanced intravenous solutions has been advocated to avoid these complications.
机译:静脉注射液(IVFS)是住院患者中最常用的药物。知识IVFS的适应症和药代动力学对所有医学学科都至关重要。等渗盐水(正常盐水,0.9%NS)是最利用的静脉内溶液。等渗盐水有效地扩展血管内隔室,因为四分之一的输注静脉血管内,而剩余的四分之三进入间隙空间。在不同的临床情景中正确使用IVFS是至关重要的。 IVF在其半衰期方面不同,血管内体积扩展,准备和成本方面不同。由于其相对较低的成本和可用性,更常用的晶体更常用。胶体在休克或出血的情况下是非常有利的,因为它们保留在血管内空间中,从而促进血液给药之前的血压(BP)增加。胶体在烧伤和严重的低血糖血症血症的情况下也是有利的。人类白蛋白(5%,20%和25%)是最常用的胶体溶液。它仍然存在血管内提供,并且在系统性炎症中没有毛细血管泄漏。住院患者的目标是及时且足够的静脉内流体复苏。大量的等渗盐水的利用可能导致高血芽尿,高鼻血症,高氯血症,代谢酸中毒和低钾血症。已经提倡使用平衡的静脉溶液以避免这些并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号